| |
| |
|
| Insider
Information: |
Maduck Sean |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
85,222 |
|
|
Indirect Shares
|
20,000 |
|
|
| Direct
Value |
$2,439,054 |
|
|
|
Indirect Value
|
$572,400 |
|
|
| Total
Shares |
105,222 |
|
|
| Total
Value |
$3,011,454 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -73.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-05-13 |
85,222 |
2024-05-13 |
20,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-09-01 |
4 |
OE |
$3.29 |
$82,250 |
D/D |
25,000 |
65,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-10-01 |
4 |
OE |
$3.29 |
$80,154 |
D/D |
24,363 |
64,387 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-10-05 |
4 |
OE |
$3.29 |
$2,096 |
D/D |
637 |
40,661 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-09-01 |
4 |
OE |
$3.29 |
$82,250 |
D/D |
25,000 |
79,618 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-10-03 |
4 |
OE |
$3.29 |
$82,250 |
D/D |
25,000 |
81,462 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-11-10 |
4 |
OE |
$3.29 |
$82,250 |
D/D |
25,000 |
81,462 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-12-01 |
4 |
OE |
$3.29 |
$2,056 |
D/D |
625 |
57,087 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-02-15 |
4 |
OE |
$3.29 |
$15,660 |
D/D |
4,760 |
79,215 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-02-16 |
4 |
OE |
$3.29 |
$97,811 |
D/D |
27,068 |
101,523 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-03-18 |
4 |
OE |
$3.88 |
$66,810 |
D/D |
17,219 |
92,441 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-03-27 |
4 |
OE |
$3.88 |
$100,698 |
D/D |
25,953 |
111,175 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-05-13 |
4 |
OE |
$3.88 |
$194,000 |
D/D |
50,000 |
135,222 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2018-12-12 |
4 |
S |
$19.01 |
$1,140,366 |
D/D |
(60,000) |
20,024 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-10-01 |
4 |
AS |
$20.00 |
$487,375 |
D/D |
(24,363) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-10-05 |
4 |
AS |
$20.00 |
$12,740 |
D/D |
(637) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-08-03 |
4 |
AS |
$21.18 |
$529,420 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-09-01 |
4 |
AS |
$21.40 |
$534,930 |
D/D |
(25,000) |
40,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-07-07 |
4 |
AS |
$22.19 |
$554,693 |
D/D |
(25,000) |
30,024 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-03-01 |
4 |
D |
$24.06 |
$12,150 |
D/D |
(505) |
73,950 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-02-15 |
4 |
AS |
$25.00 |
$119,000 |
D/D |
(4,760) |
74,455 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-03-18 |
4 |
AS |
$25.00 |
$430,475 |
D/D |
(17,219) |
75,222 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2024-03-27 |
4 |
AS |
$25.01 |
$649,025 |
D/D |
(25,953) |
85,222 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-12-01 |
4 |
AS |
$25.28 |
$15,800 |
D/D |
(625) |
56,462 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2023-12-01 |
4 |
AS |
$25.56 |
$639,048 |
D/D |
(25,000) |
73,291 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
See Remarks |
• – – |
2022-11-10 |
4 |
AS |
$25.57 |
$639,250 |
D/D |
(25,000) |
56,462 |
0 |
% |
|
64 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
